Archived

Single Source: Bench to Bassinet Congenital Heart disease Advancing New understanding in GEnomics Cohort (B2B CHANGE Cohort) Data Coordinating Center (U01 Clinical Trial Not Allowed)

Federal funding opportunity RFA-HL-26-007 from National Institutes of Health (Department of Health and Human Services).

Posted: January 10, 2025
Closed: March 18, 2025
Award ceiling: $4,010,000
Cost sharing: No
Instrument: Cooperative Agreement
Assistance listing: 93.837
Category: Health
Archives: April 23, 2025

Program funding history

Awards made under Assistance Listing 93.837 across FY2025–FY2027, from public federal spending records.

FY2025 obligated: $3B
FY2026 obligated: $3B
FY2027 (to date) obligated: $0
Awards in window: 10,712

Top recipients: Trustees of the University of Pennsylvania, the, Brigham & Womens Hospital Inc, University of Pittsburgh - of the Commonwealth System of Higher Education, Regents of the University of Michigan, The Leland Stanford Junior University

Source: USAspending.gov · refreshed October 2026 · Program page: awards, recipients and the opportunities under this listing →

This opportunity is archived. Applications are no longer accepted. Similar grants are listed below, and the free Tuesday digest carries the next ones like it.

Synopsis

The B2B Pediatric Cardiac Genomics Consortium (PCGC) (http://www.benchtobassinet.com/) will evolve to the B2B CHANGE Cohort (Congenital Heart disease Advancing New understanding in GEnomics). The B2B CHANGE Cohorts mission will be to conduct long-term clinical follow up on participants from the original PCGC Cohort, to perform deeper cohort phenotyping and to support investigators in applying for funding to conduct multi-center, collaborative ancillary studies to further understand how genetic variants relate to clinical outcomes. The Administrative Coordinating Center (ACC) will serve to lead and advance data and resource management and sharing, and coordinate critical data collection and participant outreach efforts at the clinical research sites. The ACC will work in a collaborative fashion with site PIs, as well as the broader congenital heart disease (CHD) research community.

Who can apply

Public and State controlled institutions of higher education

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. Only the following applicant is eligible to apply for this single source funding: Cincinnati Children's Hospital Medical Center.

The official record

Grants.gov published the official terms and dates of this opportunity; this page keeps them as they were listed.

View on Grants.gov Full announcement

Agency contact: National Institutes of Health · [email protected] · 301-402-2541

New to federal funding? How to read an announcement · Who can apply · How grants work

Tell me when this program posts again

This round has closed. One email the morning after this program is posted again under a new number (we watch for about two years), and one more about a week before that round closes (the next morning, if it is already closer than that). That is all this sends — it is not a newsletter signup.

Stored once per grant, used only for this watch’s emails; every one carries a one-click unsubscribe. Privacy

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.

No spam, ever. Privacy

Similar grants

Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
PAR-27-013 · National Institutes of Health · closes November 2, 2028
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
PAR-27-012 · National Institutes of Health · closes November 2, 2028
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
PA-24-254 · National Institutes of Health · closes July 12, 2027
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
RFA-HL-26-019 · National Institutes of Health · closes December 23, 2027
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
PAR-25-447 · National Institutes of Health · closes May 8, 2028
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
PAR-27-011 · National Institutes of Health · closes November 2, 2028

Same-day alerts, matched to you

The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31.

Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.

See pricing